Guadalquiver, Ayron Blaize P.

HRN: 21-47-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CEFUROXIME 750MG (VIAL)
06/20/2022
06/27/2022
IV
400mg
Q8h
Pcap C
Waiting Final Action 
06/24/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
06/24/2022
06/30/2022
ORAL
3.6ml
Q12Hrs
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: